PRODUCTS
ZytoDot ® 2C SPEC ERG Break Apart Probe
The ZytoDot ® 2C SPEC ERG Break Apart Probe is designed to detect aberrations involving the ERG gene at 21q22.2 frequently found in prostate cancers. ERG rearrangements have been observed in 40-60% of prostate cancers identified via prostate-specific antigen screening. The most common aberration affecting ERG is the interstitial deletion of about 3 Mb at the chromosomal region 21q22 found in 90% of the cases.
Probe Maps
Ordering Information
| Prod. No.: | Tests¹ (Volume): | Registration Status²: | ||
|---|---|---|---|---|
| C-3058-400 |
|
 |
Download Information
| 1 | Using 10 μl probe solution per test. |
| 2 | In vitro diagnostic medical device according to EU directive 98/79/EC. CE IVD only available in certain countries. All other countries research use only! Please contact your local dealer for more information. |
